NOELLE REDMON: Open Payments
NPI 1639248511 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 54 payments from 16 companies in 2025. Trend: 2023 $1,225 · 2024 $1,230 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $157 |
| Novo Nordisk Inc | 9 | $136 |
| GlaxoSmithKline, LLC. | 6 | $114 |
| Amgen Inc. | 4 | $63 |
| Abbott Laboratories | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
| Astellas Pharma US Inc | 3 | $43 |
| Boston Scientific Corporation | 1 | $24 |
Products named: Ozempic, NURTEC ODT, SHINGRIX, EVENITY, FREESTYLE LIBRE 3, VOQUEZNA, ELIQUIS, JARDIANCE.
Industry payments across NC — which companies pay providers there.
